The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust (QEH) 2022 - 2027 (2526-216 (CV43))

Description

Lot 1: Norfolk and Waveney ICB have awarded QEHKL funding to provide a Targeted Lung Cancer Screening Programme. The annual recurring costs are as follows: 1.0 WTE Band 7 £63,000 1.0 WTE Band 3 £33,000 1 PA for the responsible clinician and radiologist £14,400 This funding is recurrent to 31 March 2029, at which point this will become a national screening programme. There has been a delay in starting the programme in 2025, and it is expected that the costs for this year will be reduced accordingly In addition, there is non-recurrent funding for 0.5 PA for 6 months of £3,600. The total potential cost is £445,200, as long as the option to extend on the contract is exercised. The effective date for this modification is 11th November 2025 and the value is £445,200 to 31 March 2029. There is no change in contract dates or term which remains remains 1 April 2022 - 31 March 2030, inclusive of 3 year option to extend.